Effects of Transcutaneous Spinal Direct Current Stimulation on Mobility in Cases With Multiple Sclerosis

CompletedNot a drug-phase studyMS (type not specified)NCT06110936

We could not find results for this trial

What it found

No results found

We found no results in the registry or in papers.

This trial finished 2 years ago. We found no results in the registry or in any paper that cites it.

What was tested

Treatment tested

  • Transcutaneous Spinal Direct Current Stimulation

What it measured

Main measures

  • Timed 25-Foot Walk (T25-FW)

    It will be evaluated twice: immediately before and immediately after 2 weeks treatment.

    Disability progressionWalking and mobility
  • Time Up and Go (TUG)

    It will be evaluated twice: immediately before and immediately after 2 weeks treatment.

    Walking and mobility
  • Multiple Sclerosis Walking Scale-12 (MSWS-12)

    It will be evaluated twice:immediately before and immediately after 2 weeks treatment.

    Walking and mobility
  • Gait Speed Assessment

    It will be evaluated twice: immediately before and immediately after 2 weeks treatment.

    Walking and mobility

Other measures (2)

  • Fatigue Severity Scale (FSS)

    It will be evaluated twice: immediately before and immediately after 2 weeks treatment.

    Fatigue
  • Fatigue Impact Scale (FIS)

    It will be evaluated twice: immediately before and immediately after 2 weeks treatment.

    Thinking and memoryFatigue

Who could take part

MS (type not specified) · 18 and over · EDSS 2 to 6

Show the full criteria

Inclusion criteria

* Patients diagnosed with MS and suffering from walking difficulties due to MS * EDSS score between 2-6 * Being over 18 years old

Exclusion criteria

* Relapsed within the last two months * Changed medication within 45 days * Hospitalized in the last three months * Had other neurological or musculoskeletal problems * Had an obstacle to stimulation (skin problems, metal implants, etc.) * Do not want to participate in the study individuals

As registered. Criteria can change, so ask the trial team or your neurologist.

About this trial

In the sponsor's words

The primer aim of the study is to examine the effects of the transcutaneous spinal direct current stimulation (ts-DCS) on mobility in addition to the physiotherapy program to individuals with multiple sclerosis. Our secondary aim is to show the relationship of these effects with ts-DCS through fatigue and quality of life evaluations.

Loading reviews and guidelines…

History

    1. Started

      Nov 2023

    2. Main results due

      Mar 2024

    3. Finished

      Mar 2024

    Assembled by software from public sources.